Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration: The COMPLETE Study

PURPOSE: To evaluate the effect of eculizumab, a systemic inhibitor of complement component (C5), on the growth of geographic atrophy (GA) in patients with age-related macular degeneration (AMD). DESIGN: Prospective, double-masked, randomized clinical trial. PARTICIPANTS: Patients with GA measuring...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yehoshua, Zohar, Filho, Carlos Alexandre de Amorim Garcia, Nunes, Renata Portella, Gregori, Giovanni, Penha, Fernando M., Moshfeghi, Andrew A., Zhang, Kang, Sadda, SriniVas, Feuer, William, Rosenfeld, Philip J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015213/
https://ncbi.nlm.nih.gov/pubmed/24289920
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2013.09.044
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky